WNT1 (Wnt family member 1)
WNT1, a member of the WNT gene family comprising nineteen secreted glycoproteins, encodes a canonical ligand that plays a pivotal role in embryonic development, tissue homeostasis, and cellular fate determination. As a classic activator of the WNT/β-catenin signaling pathway, the WNT1 protein binds to Frizzled receptors and LRP5/6 co-receptors on the cell surface, thereby inhibiting the degradation of β-catenin and facilitating its nuclear translocation to drive the transcription of target genes such as MYC and CCND1. This signaling cascade is critical for orchestrating processes including midbrain development, osteoblast differentiation, and mammary gland morphogenesis, all of which rely on the conserved cysteine residues within WNT proteins that enable proper ligand folding and secretion. The gene exhibits significant tissue-specific expression in the nervous system, skeletal tissues, and breast, where it functions via autocrine or paracrine mechanisms to regulate cell proliferation and differentiation. Disruption of WNT1 function has profound clinical implications; loss-of-function mutations are associated with early-onset osteoporosis characterized by reduced bone density and increased fracture susceptibility, as well as pediatric neurodevelopmental disorders such as cerebellar malformations. Conversely, aberrant overexpression or constitutive activation of the WNT pathway by WNT1 can drive oncogenesis by promoting uncontrolled cell proliferation, contributing to the development of malignancies such as breast cancer and medulloblastoma. Thus, WNT1 serves as a key regulator of developmental patterning and adult tissue regeneration, maintaining a delicate balance where its dysregulation leads to either structural defects in bone and neural tissues or the initiation of cancerous growth.
Gene Ontology
Subcellular localization of WNT1 (and its protein):
- plasma membrane
- cytoplasm
- extracellular
- golgi
- vesicle
- cytoskeleton
- endoplasmic reticulum
- nucleus
- endosome
- lysosome
- mitochondrion
Gene Ontology (GO) terms for WNT1:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| 4310 Wnt signaling pathway [PATH:hsa04310] |
| 4340 Hedgehog signaling pathway [PATH:hsa04340] |
| 4390 Hippo signaling pathway [PATH:hsa04390] |
| 4550 Signaling pathways regulating pluripotency of stem cells [PATH:hsa04550] |
| 4916 Melanogenesis [PATH:hsa04916] |
| 5200 Pathways in cancer [PATH:hsa05200] |
| 5205 Proteoglycans in cancer [PATH:hsa05205] |
| 5217 Basal cell carcinoma [PATH:hsa05217] |
| 5166 HTLV-I infection [PATH:hsa05166] |
| Name |
|---|
| beta-catenin independent WNT signaling |
| Class B/2 (Secretin family receptors) |
| Developmental Biology |
| disassembly of the destruction complex and recruitment of AXIN to the membrane |
| GPCR ligand binding |
| PCP/CE pathway |
| Signaling by Wnt |
| TCF dependent signaling in response to WNT |
| Transcriptional regulation of white adipocyte differentiation |
| WNT ligand biogenesis and trafficking |
| Disease | Score | NofPmids | NofSnps | Source |
| OSTEOGENESIS IMPERFECTA, TYPE XV | 0.24 | 2 | 7 | CLINVAR_UNIPROT |
| Osteoporosis | 0.120542884 | 4 | 0 | BeFree_UNIPROT |
| Osteogenesis imperfecta type III (disorder) | 0.120271442 | 1 | 0 | BeFree_ORPHANET |
| Osteogenesis imperfecta type IV (disorder) | 0.120271442 | 1 | 0 | BeFree_ORPHANET |
| Malignant neoplasm of breast | 0.083528744 | 13 | 0 | BeFree_MGD |
| Mammary Neoplasms | 0.010877538 | 22 | 0 | BeFree_LHGDN |
| Liver carcinoma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
| Neurodegenerative Disorders | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Liver neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Breast Carcinoma | 0.002985861 | 11 | 0 | BeFree |
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
